GILEAD SCIENCES, INC. (GILD)
Data as of , from SEC Form 4 filings.
See up to 3 months of GILD. The 7-day demo opens the 1M and 3M ranges and puts GILD on your watchlist.
Start 7-day demoLatest GILD insider trades
About GILEAD SCIENCES, INC. (GILD)
The SEC lists GILEAD SCIENCES, INC. under CIK 0000882095, in biological products (no diagnostic substances). We track it alongside the rest of the Health Care sector.
GILD Form 4 activity by transaction type, last 90 days
| Form 4 transaction type | Transactions | Shares | Total value |
|---|---|---|---|
| Open-market sale | 26 | 111,000 | $15.72M |
| Option exercise | 29 | 143,444 | |
| Tax withholding / forfeiture | 7 | 11,148 |
Dollar totals cover purchases and sales only (codes P and S). Grants, option exercises, gifts and tax withholding are counted in shares, because none of them is a trade at a market price.
GILD insider transactions (Form 4)
95112 Form 4 filings on record, the earliest from Oct 2, 2024, newest first. Filing history page 1 of 3.
| Date | Insider | Transaction | Security | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Daniel Patrick O'Day - Officer | Open-market sale | Common Stock | 12,000 | $147.72 footnote F2 | $1.77M | |
| Daniel Patrick O'Day - Officer | Open-market sale | Common Stock | 3,000 | $148.63 footnote F3 | $446K | |
| ||||||
| Erin Burkhart - Officer | Option exercise | Common Stock | 2,223 | - footnote F1 | - | |
| Erin Burkhart - Officer | Tax withholding / forfeiture | Common Stock | 768 | $152.67 | $117K | |
| Erin Burkhart - Officer | Option exercise | Restricted Stock Unit | 2,223 | - footnote F1 | - | |
| ||||||
| Open-market sale | Common Stock | 3,000 | $145.29 | $436K | ||
| Johanna Mercier - Officer | Open-market sale | Common Stock | 1,600 | $143.69 footnote F2 | $230K | |
| Johanna Mercier - Officer | Open-market sale | Common Stock | 800 | $144.46 footnote F3 | $116K | |
| Johanna Mercier - Officer | Open-market sale | Common Stock | 600 | $145.29 | $87K | |
| ||||||
| Option exercise | Common Stock | 2,797 | - footnote F1 | - | ||
| Tax withholding / forfeiture | Common Stock | 1,347 | $144.81 | $195K | ||
| Option exercise | Restricted Stock Unit | 2,797 | - footnote F1 | - | ||
| ||||||
| Dietmar Berger - Officer | Option exercise | Common Stock | 533 | - footnote F1 | - | |
| Dietmar Berger - Officer | Tax withholding / forfeiture | Common Stock | 263 | $144.81 | $38K | |
| Dietmar Berger - Officer | Option exercise | Restricted Stock Unit | 533 | - footnote F1 | - | |
| ||||||
| Johanna Mercier - Officer | Option exercise | Common Stock | 2,797 | - footnote F1 | - | |
| Johanna Mercier - Officer | Tax withholding / forfeiture | Common Stock | 1,347 | $144.81 | $195K | |
| Johanna Mercier - Officer | Option exercise | Restricted Stock Unit | 2,797 | - footnote F1 | - | |
| ||||||
| Wettan Keeley M. Cain - Officer | Option exercise | Common Stock | 590 | - footnote F1 | - | |
| Wettan Keeley M. Cain - Officer | Tax withholding / forfeiture | Common Stock | 285 | $144.81 | $41K | |
| Wettan Keeley M. Cain - Officer | Option exercise | Restricted Stock Unit | 590 | - footnote F1 | - | |
| ||||||
| Daniel Patrick O'Day - Officer | Option exercise | Common Stock | 8,780 | - footnote F1 | - | |
| Daniel Patrick O'Day - Officer | Tax withholding / forfeiture | Common Stock | 4,230 | $144.81 | $613K | |
| Daniel Patrick O'Day - Officer | Option exercise | Restricted Stock Unit | 8,780 | - footnote F1 | - | |
| ||||||
| Daniel Patrick O'Day - Officer | Open-market sale | Common Stock | 1,600 | $147.51 footnote F2 | $236K | |
| Daniel Patrick O'Day - Officer | Open-market sale | Common Stock | 7,992 | $148.36 footnote F3 | $1.19M | |
| Daniel Patrick O'Day - Officer | Open-market sale | Common Stock | 5,408 | $149.38 footnote F4 | $808K | |
| ||||||
| Anthony Welters - Director | Option exercise | Common Stock | 7,718 | $60.67 | $468K | |
| Anthony Welters - Director | Open-market sale | Common Stock | 3,118 | $148.31 footnote F2 | $462K | |
| Anthony Welters - Director | Open-market sale | Common Stock | 4,600 | $148.82 footnote F3 | $685K | |
| Anthony Welters - Director | Option exercise | Common Stock | 10,282 | $61.35 | $631K | |
| Anthony Welters - Director | Open-market sale | Common Stock | 3,402 | $148.24 footnote F4 | $504K | |
| Anthony Welters - Director | Open-market sale | Common Stock | 6,880 | $148.82 footnote F5 | $1.02M | |
| Anthony Welters - Director | Option exercise | Non-qualified Stock Option (Right to Buy) | 7,718 | $0.00 | - | |
| Anthony Welters - Director | Option exercise | Non-qualified Stock Option (Right to Buy) | 10,282 | $0.00 | - | |
| ||||||
| Jeffrey Bluestone - Director | Option exercise | Common Stock | 1,165 | $67.45 | $79K | |
| Jeffrey Bluestone - Director | Open-market sale | Common Stock | 1,165 | $143.75 footnote F2 | $167K | |
| Jeffrey Bluestone - Director | Option exercise | Common Stock | 1,816 | $67.45 | $122K | |
| Jeffrey Bluestone - Director | Open-market sale | Common Stock | 1,816 | $144.92 footnote F3 | $263K | |
| Jeffrey Bluestone - Director | Option exercise | Common Stock | 1,658 | $67.45 | $112K | |
| Jeffrey Bluestone - Director | Open-market sale | Common Stock | 1,658 | $145.73 footnote F4 | $242K | |
| Jeffrey Bluestone - Director | Option exercise | Common Stock | 26 | $67.45 | $2K | |
| Jeffrey Bluestone - Director | Open-market sale | Common Stock | 26 | $146.36 | $4K | |
| Jeffrey Bluestone - Director | Option exercise | Common Stock | 335 | $61.35 | $21K | |
| Jeffrey Bluestone - Director | Open-market sale | Common Stock | 335 | $146.26 | $49K | |
| Jeffrey Bluestone - Director | Option exercise | Non-qualified Stock Option (Right to Buy) | 4,665 | $0.00 | - | |
| Jeffrey Bluestone - Director | Option exercise | Non-qualified Stock Option (Right to Buy) | 335 | $0.00 | - | |
| ||||||
| Open-market sale | Common Stock | 3,000 | $138.36 | $415K | ||
| Johanna Mercier - Officer | Option exercise | Common Stock | 1,890 | $72.34 | $137K | |
| Johanna Mercier - Officer | Option exercise | Common Stock | 23,110 | $66.64 | $1.54M | |
| Johanna Mercier - Officer | Open-market sale | Common Stock | 16,530 | $137.37 footnote F2 | $2.27M | |
| Johanna Mercier - Officer | Open-market sale | Common Stock | 11,470 | $138.04 footnote F3 | $1.58M | |
| Johanna Mercier - Officer | Option exercise | Non-qualified Stock Option (Right to Buy) | 23,110 | $0.00 | - | |
| Johanna Mercier - Officer | Option exercise | Non-qualified Stock Option (Right to Buy) | 1,890 | $0.00 | - | |
| ||||||
| Wettan Keeley M. Cain - Officer | Option exercise | Common Stock | 6,002 | - footnote F1 | - | |
| Wettan Keeley M. Cain - Officer | Tax withholding / forfeiture | Common Stock | 2,908 | $133.06 | $387K | |
| Wettan Keeley M. Cain - Officer | Option exercise | Restricted Stock Unit | 6,002 | - footnote F1 | - | |
| ||||||
| Daniel Patrick O'Day - Officer | Open-market sale | Common Stock | 6,700 | $129.66 footnote F2 | $869K | |
| Daniel Patrick O'Day - Officer | Open-market sale | Common Stock | 7,700 | $130.80 footnote F3 | $1.01M | |
| Daniel Patrick O'Day - Officer | Open-market sale | Common Stock | 600 | $131.34 footnote F4 | $79K | |
| ||||||
| Open-market sale | Common Stock | 3,000 | $129.93 footnote F2 | $390K | ||
| ||||||
| Johanna Mercier - Officer | Open-market sale | Common Stock | 3,000 | $129.92 footnote F2 | $390K | |
| ||||||
| Daniel Patrick O'Day - Officer | Open-market sale | Common Stock | 11,900 | $126.09 footnote F2 | $1.50M | |
| Daniel Patrick O'Day - Officer | Open-market sale | Common Stock | 3,100 | $127.08 footnote F3 | $394K | |
| ||||||
| Johanna Mercier - Officer | Open-market sale | Common Stock | 1,480 | $123.42 footnote F2 | $183K | |
| Johanna Mercier - Officer | Open-market sale | Common Stock | 1,070 | $124.00 footnote F3 | $133K | |
| Johanna Mercier - Officer | Open-market sale | Common Stock | 450 | $125.40 | $56K | |
| ||||||
| Open-market sale | Common Stock | 3,000 | $125.40 | $376K | ||
| Dietmar Berger - Officer | Tax withholding / forfeiture | Common Stock | 263 | $121.48 | $32K | |
| Dietmar Berger - Officer | Option exercise | Common Stock | 533 | - footnote F1 | - | |
| Dietmar Berger - Officer | Option exercise | Restricted Stock Unit | 533 | - footnote F1 | - | |
| ||||||
| Wettan Keeley M. Cain - Officer | Tax withholding / forfeiture | Common Stock | 283 | $121.48 | $34K | |
| Wettan Keeley M. Cain - Officer | Option exercise | Common Stock | 589 | - footnote F1 | - | |
| Wettan Keeley M. Cain - Officer | Option exercise | Restricted Stock Unit | 589 | - footnote F1 | - | |
| ||||||
| Tax withholding / forfeiture | Common Stock | 1,341 | $121.48 | $163K | ||
| Option exercise | Common Stock | 2,796 | - footnote F1 | - | ||
| Option exercise | Restricted Stock Unit | 2,796 | - footnote F1 | - | ||
| ||||||
| Johanna Mercier - Officer | Option exercise | Restricted Stock Unit | 2,796 | - footnote F1 | - | |
| Johanna Mercier - Officer | Tax withholding / forfeiture | Common Stock | 1,341 | $121.48 | $163K | |
| Johanna Mercier - Officer | Option exercise | Common Stock | 2,796 | - footnote F1 | - | |
| ||||||
| Daniel Patrick O'Day - Officer | Tax withholding / forfeiture | Common Stock | 4,213 | $121.48 | $512K | |
| Daniel Patrick O'Day - Officer | Option exercise | Common Stock | 8,779 | - footnote F1 | - | |
| Daniel Patrick O'Day - Officer | Option exercise | Restricted Stock Unit | 8,779 | - footnote F1 | - | |
| ||||||
| Daniel Patrick O'Day - Officer | Open-market sale | Common Stock | 10,900 | $131.10 footnote F2 | $1.43M | |
| Daniel Patrick O'Day - Officer | Open-market sale | Common Stock | 3,062 | $132.22 footnote F3 | $405K | |
| Daniel Patrick O'Day - Officer | Open-market sale | Common Stock | 1,038 | $132.97 footnote F4 | $138K | |
| ||||||
| Open-market sale | Common Stock | 3,000 | $132.27 | $397K | ||
| Johanna Mercier - Officer | Option exercise | Common Stock | 25,000 | $66.64 | $1.67M | |
| Johanna Mercier - Officer | Open-market sale | Common Stock | 7,749 | $130.29 footnote F2 | $1.01M | |
| Johanna Mercier - Officer | Open-market sale | Common Stock | 11,177 | $131.19 footnote F3 | $1.47M | |
| Johanna Mercier - Officer | Open-market sale | Common Stock | 8,374 | $132.23 footnote F4 | $1.11M | |
| Johanna Mercier - Officer | Open-market sale | Common Stock | 700 | $132.75 footnote F5 | $93K | |
| Johanna Mercier - Officer | Option exercise | Non-qualified Stock Option (Right to Buy) | 25,000 | $0.00 | - | |
| ||||||
| Jeffrey Bluestone - Director | Grant or award | Common Stock | 1,146 | $0.00 | - | |
| Jeffrey Bluestone - Director | Grant or award | Non-qualified Stock Option (Right to Buy) | 4,884 | $0.00 | - | |
Recent GILD Form 144 notices of proposed sale
3An insider files Form 144 before selling restricted or control stock. It announces a planned sale. If the sale goes ahead, it shows up later on a Form 4.
| Filed | Filer | Relationship | Shares | Market value | Notice |
|---|---|---|---|---|---|
| ANDREW DICKINSON | Officer | 3,000 | $436K | View on EDGAR | |
| JOHANNA MERCIER | Officer | 3,000 | $433K | View on EDGAR | |
| ANTHONY WELTERS | Director | 18,000 | $2.68M | View on EDGAR |
Stock trades in GILD disclosed by members of the U.S. House in the last 12 months, newest first. Values are the ranges as filed.
| Member | Type | Traded | Disclosed | Value range | Owner | Days to disclose | Filing |
|---|---|---|---|---|---|---|---|
| Purchase | $1,001 to $15,000 | Member | 44 days | Original filing | |||
| Purchase | $1,001 to $15,000 | Dependent child | 44 days | Original filing | |||
| Purchase | $1,001 to $15,000 | Joint | 30 days | Original filing |
House of Representatives Periodic Transaction Reports from 2024. Senate filings are not included yet. The full history of GILD beside its insider purchases is in the Congress Tracker.
GILD insider trading FAQ
What is the latest insider trade for GILD?
GILEAD SCIENCES, INC. (GILD) had 18 insider filings in the last 90 days, with the most recent on 2026-10-02. The full record for GILD runs to 112 Form 4 filings, the earliest from 2024-10-02. InsiderAlpha adds new Form 4, Form 144 and 8-K filings as they arrive from SEC EDGAR.
How many insiders are buying GILD stock?
No insider purchases of GILD were filed in the last 90 days.
How many insiders are selling GILD stock?
26 insider sales of GILD were filed in the last 90 days, totaling $15.72M.
Where can I see GILD SEC filings (Form 4, 10-K, 10-Q, 8-K)?
This page collects GILD Form 4 insider transactions, Form 144 sale notices and 8-K filings in one place. Annual 10-K and quarterly 10-Q reports live on the company's SEC EDGAR page.
More Health Care companies with insider activity
Recent insider filings
10The EDGAR links open each original Form 4, so you can check any number on this page against the filing it came from.
- - Daniel Patrick O'Day view on EDGAR
- - Erin Burkhart view on EDGAR
- - Andrew D. Dickinson view on EDGAR
- - Johanna Mercier view on EDGAR
- - Andrew D. Dickinson view on EDGAR
- - Dietmar Berger view on EDGAR
- - Johanna Mercier view on EDGAR
- - Wettan Keeley M. Cain view on EDGAR
- - Daniel Patrick O'Day view on EDGAR
- - Daniel Patrick O'Day view on EDGAR
Related companies with recent insider activity
Learn more
- Insider selling: signal or noise?
- Why most insider sales are routine, and the few patterns worth a second look.
- Form 144 vs Form 4
- A Form 144 announces a planned sale; the Form 4 reports it after it happens.
- Insider activity in Health Care
- Where GILD's peers are being bought and sold.
- Every recent Form 4
- The market-wide feed, updated as filings arrive from SEC EDGAR.
Follow GILD with a 7-day demo
- GILD on your watchlist
- Every GILD Form 4 filing on record
- Up to 3 months of GILD price history
- The daily trading plan of ranked insider buys, on a delay, with the plan archive